| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.31 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.32 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |